Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

86,200 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Suprasternal Versus Transfemoral Access for Transcatheter Aortic Valve Replacement: Insights From a Propensity Score Matched Analysis.
Brener MI, Olds A, Nemeth S, Kurlansky P, Nazif TM, Vahl TP, Khalique OK, Hamid NB, Patel A, Ng VG, Chen S, Cahill TJ, Rahim HM, Hahn RT, Bapat V, Sarraf M, Ahmed MI, Leon MB, Kodali S, Eudailey KW, George I. Brener MI, et al. Among authors: chen s. J Am Heart Assoc. 2021 Aug 17;10(16):e020491. doi: 10.1161/JAHA.120.020491. Epub 2021 Aug 11. J Am Heart Assoc. 2021. PMID: 34376060 Free PMC article.
Radial versus femoral artery access in patients undergoing PCI for left main coronary artery disease: analysis from the EXCEL trial.
Chen S, Redfors B, Liu Y, Ben-Yehuda O, Morice MC, Leon MB, Kandzari DE, Mehran R, Lembo NJ, Banning AP, Merkely B, Kappetein AP, Sabik JF 3rd, Serruys PW, Stone GW. Chen S, et al. EuroIntervention. 2018 Nov 20;14(10):1104-1111. doi: 10.4244/EIJ-D-18-00711. EuroIntervention. 2018. PMID: 30111521 Free article. Clinical Trial.
Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Prior Cardiac Surgery in the Randomized PARTNER 2A Trial.
Chen S, Redfors B, Ben-Yehuda O, Crowley A, Greason KL, Alu MC, Finn MT, Vahl TP, Nazif T, Thourani VH, Suri RM, Svensson L, Webb JG, Kodali SK, Leon MB. Chen S, et al. JACC Cardiovasc Interv. 2018 Nov 12;11(21):2207-2216. doi: 10.1016/j.jcin.2018.08.006. Epub 2018 Aug 28. JACC Cardiovasc Interv. 2018. PMID: 30409278 Free article. Clinical Trial.
Impact of large periprocedural myocardial infarction on mortality after percutaneous coronary intervention and coronary artery bypass grafting for left main disease: an analysis from the EXCEL trial.
Ben-Yehuda O, Chen S, Redfors B, McAndrew T, Crowley A, Kosmidou I, Kandzari DE, Puskas JD, Morice MC, Taggart DP, Leon MB, Lembo NJ, Brown WM, Simonton CA, Dressler O, Kappetein AP, Sabik JF, Serruys PW, Stone GW. Ben-Yehuda O, et al. Among authors: chen s. Eur Heart J. 2019 Jun 21;40(24):1930-1941. doi: 10.1093/eurheartj/ehz113. Eur Heart J. 2019. PMID: 30919909 Clinical Trial.
The initial U.S. experience with the Tempo active fixation temporary pacing lead in structural heart interventions.
Nazif TM, Chen S, Codner P, Grossman PM, Menees DS, Sanchez CE, Yakubov SJ, White J, Kapadia S, Whisenant BK, Forrest JK, Krishnaswamy A, Arshi A, Orford JL, Leon MB, Dizon JM, Kodali SK, Chetcuti SJ. Nazif TM, et al. Among authors: chen s. Catheter Cardiovasc Interv. 2020 Apr 1;95(5):1051-1056. doi: 10.1002/ccd.28476. Epub 2019 Sep 2. Catheter Cardiovasc Interv. 2020. PMID: 31478304 Free article.
New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.
Nazif TM, Chen S, George I, Dizon JM, Hahn RT, Crowley A, Alu MC, Babaliaros V, Thourani VH, Herrmann HC, Smalling RW, Brown DL, Mack MJ, Kapadia S, Makkar R, Webb JG, Leon MB, Kodali SK. Nazif TM, et al. Among authors: chen s. Eur Heart J. 2019 Jul 14;40(27):2218-2227. doi: 10.1093/eurheartj/ehz227. Eur Heart J. 2019. PMID: 31505615
Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
Furer A, Chen S, Redfors B, Elmariah S, Pibarot P, Herrmann HC, Hahn RT, Kodali S, Thourani VH, Douglas PS, Alu MC, Fearon WF, Passeri J, Malaisrie SC, Crowley A, McAndrew T, Genereux P, Ben-Yehuda O, Leon MB, Burkhoff D. Furer A, et al. Among authors: chen s. Circ Heart Fail. 2019 Aug;12(8):e005809. doi: 10.1161/CIRCHEARTFAILURE.118.005809. Epub 2019 Aug 1. Circ Heart Fail. 2019. PMID: 31525069 Clinical Trial.
Impact of renin-angiotensin system inhibitors on clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: an analysis of from the PARTNER 2 trial and registries.
Chen S, Redfors B, Nazif T, Kirtane A, Crowley A, Ben-Yehuda O, Kapadia S, Finn MT, Goel S, Lindman BR, Alu MC, Chau KH, Thourani VH, Vahl TP, Douglas PS, Kodali SK, Leon MB. Chen S, et al. Eur Heart J. 2020 Feb 21;41(8):943-954. doi: 10.1093/eurheartj/ehz769. Eur Heart J. 2020. PMID: 31711153 Free PMC article. Clinical Trial.
Low and elevated B-type natriuretic peptide levels are associated with increased mortality in patients with preserved ejection fraction undergoing transcatheter aortic valve replacement: an analysis of the PARTNER II trial and registry.
Chen S, Redfors B, O'Neill BP, Clavel MA, Pibarot P, Elmariah S, Nazif T, Crowley A, Ben-Yehuda O, Finn MT, Alu MC, Vahl TP, Kodali S, Leon MB, Lindman BR. Chen S, et al. Eur Heart J. 2020 Feb 21;41(8):958-969. doi: 10.1093/eurheartj/ehz892. Eur Heart J. 2020. PMID: 31883339 Clinical Trial.
86,200 results
You have reached the last available page of results. Please see the User Guide for more information.